For the Inventor, By the Inventor

Enter assignee name

Dublin, Ireland

Grifols Worldwide Operations Limited

USPTO Granted Patents = 30

CIPO Patents = 2

EPO Patents = 21

Trademarks = 28

Forward Citations = 20

Loading Chart...

Loading Chart...

52 inventors (with patents filed for the assignee):

David A Ross (8 out of 12 patents)

Thomas Barnett (5 out of 9 patents)

Jordi Boira Bonhora (5 out of 16 patents)

4. Carlos Roura Salietti (5 out of 8 patents)

5. James Rebbeor (4 out of 8 patents)

6. Charles Miller (3 out of 6 patents)

7. Anthony Klos (3 out of 5 patents)

8. Eric Allgaier (3 out of 5 patents)

9. Kevin Wee (3 out of 4 patents)

10. Thomas P Zimmerman (3 out of 14 patents)

11. Kelly Glancy (3 out of 3 patents)

12. Michelle StPeter (3 out of 3 patents)

13. Joan Oriols Gaja (3 out of 3 patents)

14. Daniel Fleta Coit (3 out of 9 patents)

15. Ralph Christian Crumrine (3 out of 3 patents)

Core Competencies:

Albumin

Alpha-1 Proteinase Inhibitor

Immunoglobulin G

Therapeutic Plasma Exchange

Plasmapheresis

HIF-Related Conditions

Infection-Related Immune Conditions

Sterile Filling

Blood-Derived Products

RFID Tag

Container Sterilization

Automated Devices

30 patents: Sort by Forward Citations

1. 12734220 - Composition comprising albumin for use in the treatment of amyotrophic lateral sclerosis (ALS) by plasma exchange (2026-09-15),

2. 12721337 - Device for cooling plasma (2026-09-01),

3. 12479907 - Method for obtaining Alpha-1 proteinase inhibitor (2025-11-25),

4. 12344415 - System and method for dispensing a liquid in a closed chamber (2025-07-01),

5. 12280110 - Method for the treatment or prevention of infection-related immune conditions using a composition comprising IgM (2025-04-21),

6. 12214920 - System and method for the sterile filling of containers (2025-02-04),

7. RE50230 - Method of treatment of hypoxia inducible factor (HIF)-related conditions (2024-12-10),

8. 12144849 - Composition comprising highly-concentrated Alpha1 proteinase inhibitor and method for obtaining thereof (2024-11-19),

9. 12091444 - Intradermal administration of immunoglobulin G preparation (2024-09-17),

10. 12048794 - Device for therapeutic plasma exchange (2024-07-30),

11. 11701412 - Composition comprising highly-concentrated α1 proteinase inhibitor and method for obtaining thereof (2023-07-18),

12. 11596702 - Container for sterilizing flexible bags (2023-03-07),

13. 11395860 - Method of preparing containers for blood-derived products (2022-07-26),

14. RE49129 - Method of treatment of hypoxia inducible factor (HIF)-related conditions (2022-07-11),

15. 11253578 - Composition comprising highly-concentrated ALPHA1 proteinase inhibitor and method for obtaining thereof (2022-02-22),

Company Overview

Grifols Worldwide Operations Limited is a global leader in the healthcare sector, specializing in the development and manufacturing of plasma-derived medicines. The company focuses on innovative therapies for patients with chronic and rare diseases, leveraging advanced biopharmaceutical technologies. With a strong commitment to research and development, Grifols operates in various regions, enhancing healthcare solutions through its expertise in immunology, hematology, and other therapeutic areas, ultimately aiming to improve patient outcomes worldwide.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

30 Patents

#54 in Dublin

#88 in Ireland

#21,888 in the World

Dublin, Ireland

Grifols Worldwide Operations Limited

Forward Citations = 20

52 inventors:

David A Ross (8 out of 12 patents)

Thomas Barnett (5 out of 9 patents)

Jordi Boira Bonhora (5 out of 16 patents)

4. Carlos Roura Salietti (5 out of 8 patents)

5. James Rebbeor (4 out of 8 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Grifols Worldwide Operations Limited. Retrieved from https://idiyas.com/company/grifols-worldwide-operations

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…